HLA-A and neoplasm: We selected nine HGSC patients (Supplementary Table S1) expressing HLA-A*02:01, with pre-surgery plasma samples and sufficient solid tumor or ascites cells for both TIL expansion and DNA/RNA extraction for detailed analysis of tumor antigen/neo-antigen expression and recognition.